VERU INC. (VERU) Executive Compensation
VERU INC. (VERU) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VERU
CIK: 863894
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 09/30
State: WI
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Cherry Bekaert LLP
Auditor SinceSince 9/30/2024 12:00:00 AM
Lead Engagement PartnerMatthew Urbizo
Audit LocationAtlanta, Georgia, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-08 | 2026-09-08 | 8-K | 0001193125-26-384430 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | PRIMARY DOCUMENT | 0001042167-26-000060 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | FORM 10-Q | 0001437749-26-026664 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-341187 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-07-02 | 8-K | 0001193125-26-294507 | View SEC Doc Filr Page |
| 424B5 | 2026-07-02 | — | 424B5 | 0001193125-26-294490 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-02 | FORM 8-K | 0001437749-26-019478 | View SEC Doc Filr Page |
| S-8 | 2026-05-13 | — | FORM S-8 | 0001437749-26-016560 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | FORM 10-Q | 0001437749-26-016557 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-13 | 8-K | 0001193125-26-220569 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-04 | PRIMARY DOCUMENT | 0001042167-26-000044 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-04 | PRIMARY DOCUMENT | 0001042167-26-000043 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-04 | PRIMARY DOCUMENT | 0001042167-26-000042 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-04 | PRIMARY DOCUMENT | 0001042167-26-000041 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-04 | PRIMARY DOCUMENT | 0001042167-26-000040 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-04 | PRIMARY DOCUMENT | 0001042167-26-000039 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-04 | PRIMARY DOCUMENT | 0001042167-26-000038 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-04 | PRIMARY DOCUMENT | 0001042167-26-000037 | View SEC Doc Filr Page |
| EFFECT | 2026-04-15 | — | EFFECT Filing | 9999999995-26-001201 | View SEC Doc Filr Page |
| EFFECT | 2026-04-15 | — | EFFECT Filing | 9999999995-26-001200 | View SEC Doc Filr Page |
| CORRESP | 2026-04-13 | — | CORRESP Filing | 0001193125-26-152810 | View SEC Doc Filr Page |
| CORRESP | 2026-04-13 | — | CORRESP Filing | 0001193125-26-152807 | View SEC Doc Filr Page |
| UPLOAD | 2026-04-13 | — | UPLOAD Filing | 0000000000-26-003677 | View SEC Doc Filr Page |
| UPLOAD | 2026-04-13 | — | UPLOAD Filing | 0000000000-26-003676 | View SEC Doc Filr Page |
| S-3 | 2026-04-07 | — | S-3 | 0001193125-26-145576 | View SEC Doc Filr Page |